Advertisement
Screener

INTELLIGENT BIO SOLUTIONS INC. (INBS) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

1.6 / 5 stars · 14/43 Roast Me

INTELLIGENT BIO SOLUTIONS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.91 per share for the 12-month period ending 2025-06-30, per its 10-K filed 2025-08-15.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-08-15

  • INTELLIGENT BIO SOLUTIONS INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2024-09-30 was $1.91.
  • INTELLIGENT BIO SOLUTIONS INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $1.91.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month
2025-06-30$1.91
10-K · filed 2025-08-15
2025-03-31$1.91
10-Q · filed 2025-05-13
2024-12-31$1.91
10-Q · filed 2025-02-13
2024-09-30$1.91
10-Q · filed 2024-11-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
AETHLON MEDICAL INC (AEMD)United States$0.005B
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26